Global Cancer Diagnostics Market Insights, Forecast to 2025

がん診断の世界市場インサイト・予測(~2025年)

◆タイトル:Global Cancer Diagnostics Market Insights, Forecast to 2025
◆商品コード:DATA908B12687
◆調査・発行会社:QYResearch
◆発行日:2019年8月20日
◆ページ数:114
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥421,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥842,400見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

※本調査レポートでは、世界のがん診断市場について調査・分析し、以下の構成でお届け致します。がん診断の種類別には、プラットフォームベース、機器ベースに、用途別には、乳がん、肺がん、大腸がん、黒色腫、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別がん診断売上データ
・地域別がん診断市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別がん診断市場規模:プラットフォームベース、機器ベース
・用途別がん診断市場規模:乳がん、肺がん、大腸がん、黒色腫、その他
・主要メーカーの企業情報:Becton, Dickinson and Company、GE Healthcare、Abbott、Roche、Thermo Fisher Scientific、Agilent Technologies、Illumina、Siemens Healthcare、C.R. Bard
・がん診断の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

This report manily covers cancer diagnostics market.Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. 
The Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.
The global Cancer Diagnostics market is valued at 8990 million US$ in 2018 and will reach 23200 million US$ by the end of 2025, growing at a CAGR of 12.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Diagnostics market based on company, product type, end user and key regions.

This report studies the global market size of Cancer Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Diagnostics in these regions.
This research report categorizes the global Cancer Diagnostics market by top players/brands, region, type and end user. This report also studies the global Cancer Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard

Market size by Product
Platform-based
Instrument-based
Market size by End User
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Cancer Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cancer Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cancer Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cancer Diagnostics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cancer Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Study Coverage
1.1 Cancer Diagnostics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cancer Diagnostics Market Size Growth Rate by Product
1.4.2 Platform-based
1.4.3 Instrument-based
1.5 Market by End User
1.5.1 Global Cancer Diagnostics Market Size Growth Rate by End User
1.5.2 Breast Cancer
1.5.3 Lung Cancer
1.5.4 Colorectal Cancer
1.5.5 Melanoma
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Cancer Diagnostics Market Size
2.1.1 Global Cancer Diagnostics Revenue 2014-2025
2.1.2 Global Cancer Diagnostics Sales 2014-2025
2.2 Cancer Diagnostics Growth Rate by Regions
2.2.1 Global Cancer Diagnostics Sales by Regions
2.2.2 Global Cancer Diagnostics Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Cancer Diagnostics Sales by Manufacturers
3.1.1 Cancer Diagnostics Sales by Manufacturers
3.1.2 Cancer Diagnostics Sales Market Share by Manufacturers
3.1.3 Global Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Diagnostics Revenue by Manufacturers
3.2.1 Cancer Diagnostics Revenue by Manufacturers (2014-2019)
3.2.2 Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
3.3 Cancer Diagnostics Price by Manufacturers
3.4 Cancer Diagnostics Manufacturing Base Distribution, Product Types
3.4.1 Cancer Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Diagnostics Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Diagnostics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Cancer Diagnostics Sales by Product
4.2 Global Cancer Diagnostics Revenue by Product
4.3 Cancer Diagnostics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Cancer Diagnostics Breakdown Data by End User

6 North America
6.1 North America Cancer Diagnostics by Countries
6.1.1 North America Cancer Diagnostics Sales by Countries
6.1.2 North America Cancer Diagnostics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cancer Diagnostics by Product
6.3 North America Cancer Diagnostics by End User

7 Europe
7.1 Europe Cancer Diagnostics by Countries
7.1.1 Europe Cancer Diagnostics Sales by Countries
7.1.2 Europe Cancer Diagnostics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Diagnostics by Product
7.3 Europe Cancer Diagnostics by End User

8 Asia Pacific
8.1 Asia Pacific Cancer Diagnostics by Countries
8.1.1 Asia Pacific Cancer Diagnostics Sales by Countries
8.1.2 Asia Pacific Cancer Diagnostics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cancer Diagnostics by Product
8.3 Asia Pacific Cancer Diagnostics by End User

9 Central & South America
9.1 Central & South America Cancer Diagnostics by Countries
9.1.1 Central & South America Cancer Diagnostics Sales by Countries
9.1.2 Central & South America Cancer Diagnostics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cancer Diagnostics by Product
9.3 Central & South America Cancer Diagnostics by End User

10 Middle East and Africa
10.1 Middle East and Africa Cancer Diagnostics by Countries
10.1.1 Middle East and Africa Cancer Diagnostics Sales by Countries
10.1.2 Middle East and Africa Cancer Diagnostics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cancer Diagnostics by Product
10.3 Middle East and Africa Cancer Diagnostics by End User

11 Company Profiles
11.1 Becton, Dickinson and Company
11.1.1 Becton, Dickinson and Company Company Details
11.1.2 Company Business Overview
11.1.3 Becton, Dickinson and Company Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Becton, Dickinson and Company Cancer Diagnostics Products Offered
11.1.5 Becton, Dickinson and Company Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 Company Business Overview
11.2.3 GE Healthcare Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GE Healthcare Cancer Diagnostics Products Offered
11.2.5 GE Healthcare Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Company Business Overview
11.3.3 Abbott Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Abbott Cancer Diagnostics Products Offered
11.3.5 Abbott Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Company Business Overview
11.4.3 Roche Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Roche Cancer Diagnostics Products Offered
11.4.5 Roche Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Company Business Overview
11.5.3 Thermo Fisher Scientific Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Thermo Fisher Scientific Cancer Diagnostics Products Offered
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Company Business Overview
11.6.3 Agilent Technologies Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Agilent Technologies Cancer Diagnostics Products Offered
11.6.5 Agilent Technologies Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Company Business Overview
11.7.3 Illumina Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Illumina Cancer Diagnostics Products Offered
11.7.5 Illumina Recent Development
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Company Details
11.8.2 Company Business Overview
11.8.3 Siemens Healthcare Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Siemens Healthcare Cancer Diagnostics Products Offered
11.8.5 Siemens Healthcare Recent Development
11.9 C.R. Bard
11.9.1 C.R. Bard Company Details
11.9.2 Company Business Overview
11.9.3 C.R. Bard Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 C.R. Bard Cancer Diagnostics Products Offered
11.9.5 C.R. Bard Recent Development

12 Future Forecast
12.1 Cancer Diagnostics Market Forecast by Regions
12.1.1 Global Cancer Diagnostics Sales Forecast by Regions 2019-2025
12.1.2 Global Cancer Diagnostics Revenue Forecast by Regions 2019-2025
12.2 Cancer Diagnostics Market Forecast by Product
12.2.1 Global Cancer Diagnostics Sales Forecast by Product 2019-2025
12.2.2 Global Cancer Diagnostics Revenue Forecast by Product 2019-2025
12.3 Cancer Diagnostics Market Forecast by End User
12.4 North America Cancer Diagnostics Forecast
12.5 Europe Cancer Diagnostics Forecast
12.6 Asia Pacific Cancer Diagnostics Forecast
12.7 Central & South America Cancer Diagnostics Forecast
12.8 Middle East and Africa Cancer Diagnostics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Diagnostics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Cancer Diagnostics Product Picture
Table Cancer Diagnostics Market Segments
Table Key Manufacturers Cancer Diagnostics Covered
Table Global Cancer Diagnostics Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Cancer Diagnostics Sales Market Share by Product 2014-2025
Figure Platform-based Product Picture
Table Major Manufacturers of Platform-based
Figure Instrument-based Product Picture
Table Major Manufacturers of Instrument-based
Table Global Cancer Diagnostics Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Breast Cancer
Figure Lung Cancer
Figure Colorectal Cancer
Figure Melanoma
Figure Others
Figure Cancer Diagnostics Report Years Considered
Figure Global Cancer Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Cancer Diagnostics Sales 2014-2025 (K Units)
Table Global Cancer Diagnostics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Cancer Diagnostics Sales by Regions 2014-2019 (K Units)
Table Global Cancer Diagnostics Sales Market Share by Regions 2014-2019
Figure Global Cancer Diagnostics Sales Market Share by Regions 2014-2019
Figure 2018 Global Cancer Diagnostics Sales Market Share by Regions
Table Global Cancer Diagnostics Revenue by Regions 2014-2019 (Million US$)
Table Global Cancer Diagnostics Revenue Market Share by Regions 2014-2019
Figure Global Cancer Diagnostics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Cancer Diagnostics Revenue Market Share by Regions
Table Global Cancer Diagnostics Sales by Manufacturers (2014-2019) (K Units)
Table Global Cancer Diagnostics Sales Share by Manufacturers (2014-2019)
Figure Global Cancer Diagnostics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cancer Diagnostics Revenue by Manufacturers (2014-2019) (Million USD)
Table Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
Figure Cancer Diagnostics Value Share by Manufacturers in 2018
Table Key Manufacturers Cancer Diagnostics Price (2014-2019) (USD/Unit)
Table Cancer Diagnostics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Cancer Diagnostics Product Type
Table Date of International Manufacturers Enter into Cancer Diagnostics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Global Cancer Diagnostics Sales Share by Product (2014-2019)
Figure Global Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure Global Cancer Diagnostics Sales Market Share by Product in 2018
Table Global Cancer Diagnostics Revenue by Product (2014-2019) (Million US$)
Table Global Cancer Diagnostics Revenue Share by Product (2014-2019)
Figure Global Cancer Diagnostics Revenue Market Share by Product (2014-2019)
Figure Global Cancer Diagnostics Revenue Market Share by Product in 2018
Table Cancer Diagnostics Price by Product 2014-2019 (USD/Unit)
Table Global Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Global Cancer Diagnostics Sales Share by End User (2014-2019)
Figure Global Sales Cancer Diagnostics Market Share by End User (2014-2019)
Figure Global Sales Cancer Diagnostics Market Share by End User in 2018
Figure North America Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure North America Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table North America Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Diagnostics Sales Market Share by Countries
Table North America Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table North America Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Diagnostics Revenue Market Share by Countries
Figure United States Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure United States Cancer Diagnostics Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Canada Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table North America Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 North America Cancer Diagnostics Market Share by Product
Table North America Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table North America Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 North America Cancer Diagnostics Market Share by End User
Figure Europe Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Europe Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Europe Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Diagnostics Sales Market Share by Countries
Table Europe Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Europe Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Diagnostics Revenue Market Share by Countries
Figure Germany Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Germany Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure France Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure UK Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Italy Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Russia Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Europe Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Cancer Diagnostics Market Share by Product
Table Europe Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Europe Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Cancer Diagnostics Market Share by End User
Figure Asia Pacific Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Diagnostics Sales Market Share by Countries
Table Asia Pacific Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Diagnostics Revenue Market Share by Countries
Figure China Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure China Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure India Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Australia Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Asia Pacific Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Cancer Diagnostics Market Share by Product
Table Asia Pacific Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Asia Pacific Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Cancer Diagnostics Market Share by End User
Figure Central & South America Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Central & South America Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Diagnostics Sales Market Share by Countries
Table Central & South America Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Diagnostics Revenue Market Share by Countries
Figure Brazil Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Central & South America Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Cancer Diagnostics Market Share by Product
Table Central & South America Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Central & South America Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Cancer Diagnostics Market Share by End User
Figure Middle East and Africa Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Diagnostics Sales Market Share by Countries
Table Middle East and Africa Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Diagnostics Revenue Market Share by Countries
Figure GCC Countries Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Cancer Diagnostics Market Share by Product
Table Middle East and Africa Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Cancer Diagnostics Market Share by End User
Table Becton, Dickinson and Company Company Details
Table Becton, Dickinson and Company Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Becton, Dickinson and Company Recent Development

Table GE Healthcare Company Details
Table GE Healthcare Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare Recent Development

Table Abbott Company Details
Table Abbott Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development

Table Roche Company Details
Table Roche Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development

Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Thermo Fisher Scientific Recent Development

Table Agilent Technologies Company Details
Table Agilent Technologies Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Agilent Technologies Recent Development

Table Illumina Company Details
Table Illumina Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Illumina Recent Development

Table Siemens Healthcare Company Details
Table Siemens Healthcare Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Siemens Healthcare Recent Development

Table C.R. Bard Company Details
Table C.R. Bard Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table C.R. Bard Recent Development

Table Global Cancer Diagnostics Sales Forecast by Regions 2019-2025 (K Units)
Table Global Cancer Diagnostics Sales Market Share Forecast by Regions 2019-2025
Table Global Cancer Diagnostics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Cancer Diagnostics Revenue Market Share Forecast by Regions 2019-2025
Table Global Cancer Diagnostics Sales Forecast by Product 2019-2025 (K Units)
Table Global Cancer Diagnostics Sales Market Share Forecast by Product 2019-2025
Table Global Cancer Diagnostics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Cancer Diagnostics Revenue Market Share Forecast by Product 2019-2025
Table Global Cancer Diagnostics Sales Forecast by End User 2019-2025 (K Units)
Table Global Cancer Diagnostics Sales Market Share Forecast by End User 2019-2025
Figure North America Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Cancer Diagnostics Value Chain
Table Cancer Diagnostics Customers List
Table Cancer Diagnostics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[がん診断の世界市場インサイト・予測(~2025年)] (Global Cancer Diagnostics Market Insights, Forecast to 2025 / DATA908B12687)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆